Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gaboxadol 2-Week Efficacy Study in Primary Insomnia
NCT00209937Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Jan 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of gaboxadol in Insomnia, sponsored by Lundbeck. Started Jan 2003; status: completed.
02
Drugs
gaboxadol
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00209937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209937.